Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials

Overview of attention for article published in Cardiovascular Diabetology, June 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#48 of 1,715)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 86 X posts from 81 X users, with an upper bound of 180,300 followers.

@DanielJDrucker This might at least in part explain the benefits of ARNI on glycemic control: https://t.co/tmuUhI7aCY

これは読まないと…

RT @Office_j: 【備忘】 Int J Cardiol誌に、ネプリライシン阻害が、GLP-1分解阻害を介して血糖を低下させるとの仮説。 https://t.co/Os9EaUZLlY https://t.co/TPPBLxe0SR https://t.co/Q2u…

RT @Office_j: 【備忘】 Int J Cardiol誌に、ネプリライシン阻害が、GLP-1分解阻害を介して血糖を低下させるとの仮説。 https://t.co/Os9EaUZLlY https://t.co/Q2uSuaMRg8

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 82 additional X posts.